{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T03:13:24Z","timestamp":1773976404786,"version":"3.50.1"},"update-to":[{"DOI":"10.1002\/14651858.cd002001.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2017,7,24]],"date-time":"2017-07-24T00:00:00Z","timestamp":1500854400000}}],"reference-count":74,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2017,7,24]],"date-time":"2017-07-24T00:00:00Z","timestamp":1500854400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2017,7,24]],"date-time":"2017-07-24T00:00:00Z","timestamp":1500854400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions"}],"content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd002001.pub3","type":"journal-article","created":{"date-parts":[[2017,7,24]],"date-time":"2017-07-24T15:46:15Z","timestamp":1500911175000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Vitamin K antagonists versus low-molecular-weight heparin for the long term treatment of symptomatic venous thromboembolism"],"prefix":"10.1002","volume":"2017","author":[{"given":"Alina","family":"Andras","sequence":"first","affiliation":[{"name":"Keele University; Keele Staffordshire UK ST5 5BG"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adriano","family":"Sala Tenna","sequence":"additional","affiliation":[{"name":"Freeman Hospital; Department of Vascular Surgery; Newcastle Upon Tyne Hospitals NHS Foundation Trust Newcastle Upon Tyne UK NE7 7DN"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marlene","family":"Stewart","sequence":"additional","affiliation":[{"name":"University of Edinburgh; Usher Institute of Population Health Sciences and Informatics; Medical School, Teviot Place Edinburgh UK EH8 9AG"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2017,7,24]]},"reference":[{"issue":"6","key":"10.1002\/14651858.CD002001.pub3-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1055\/s-0037-1613395","article-title":"Enoxaparin monotherapy without oral anticoagulation to treat acute symptomatic pulmonary embolism","volume":"89","author":"Beckman","year":"2003","journal-title":"Thrombosis and Haemostasis"},{"issue":"5","key":"10.1002\/14651858.CD002001.pub3-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s002689900081","article-title":"Low-molecular-weight heparin versus warfarin for prevention of recurrent venous thromboembolism: a randomized trial","volume":"20","author":"Das","year":"1996","journal-title":"World Journal of Surgery"},{"key":"10.1002\/14651858.CD002001.pub3-BIB0003|cit3","first-page":"45","article-title":"Dalteparin prevention of recurrent DVT - a study vs. warfarin","volume":"24 Suppl 1","author":"Kakkar","year":"1994","journal-title":"Haemostasis"},{"key":"10.1002\/14651858.CD002001.pub3-BIB0004|cit4","unstructured":"Daskalopoulos M Daskalopoulos S Sfiridis P Nicolaou A Dimitroulis D Liapis C Long-term treatment of deep venous thrombosis with low molecular weight heparin: a prospective randomized trial European Society for Vascular Surgery, Programme and Abstract Book, XVII Annual Meeting and Course on Vascular Surgical Techniques 2003 73"},{"issue":"6","key":"10.1002\/14651858.CD002001.pub3-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.ejvs.2004.02.029","article-title":"Long-term treatment of deep venous thrombosis with a low molecular weight heparin (tinzaparin): a prospective randomized trial","volume":"29","author":"Daskalopoulos","year":"2005","journal-title":"European Journal of Vascular and Endovascular Surgery"},{"issue":"2","key":"10.1002\/14651858.CD002001.pub3-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0741-5214(99)70139-4","article-title":"Venographic comparison of subcutaneous low-molecular-weight heparin with oral anticoagulant therapy in the long-term treatment of deep venous thrombosis","volume":"30","author":"Gonzalez-Fajardo","year":"1999","journal-title":"Journal of Vascular Surgery"},{"key":"10.1002\/14651858.CD002001.pub3-BIB0007|cit7","first-page":"133","article-title":"Low molecular weight heparin versus coumarin in the prevention of recurrence after deep vein thrombosis","volume":"10","author":"Hamann","year":"1998","journal-title":"VASOMED"},{"issue":"1","key":"10.1002\/14651858.CD002001.pub3-BIB0008|cit8","first-page":"24","article-title":"Secondary prevention after deep venous thrombosis. Low molecular weight heparin versus coumarin","volume":"124","author":"Hamann","year":"1999","journal-title":"Zentralblatt fur Chirurgie"},{"key":"10.1002\/14651858.CD002001.pub3-BIB0010|cit9","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s003900070014","article-title":"A randomized trial of the effect of low molecular weight heparin vs. warfarin on mortality in the long-term treatment of proximal vein thrombosis","volume":"37 Suppl 1","author":"Hull","year":"2000","journal-title":"Intensivmedizin und Notfallmedizin"},{"issue":"1","key":"10.1002\/14651858.CD002001.pub3-BIB0009|cit10","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.amjmed.2006.03.030","article-title":"Self-managed long-term low-molecular-weight heparin therapy: the balance of benefits and harms","volume":"120","author":"Hull","year":"2007","journal-title":"The American Journal of Medicine"},{"issue":"11","key":"10.1002\/14651858.CD002001.pub3-BIB0012|cit11","first-page":"Abstract 1951","article-title":"Does rebound exist? A comparison of venous thromboembolic (VTE) event rates in the post-treatment period for patients randomised to long-term low-molecular-weight heparin (LMWH) versus warfarin sodium","volume":"100","author":"Hull","year":"2002","journal-title":"Blood"},{"issue":"July","key":"10.1002\/14651858.CD002001.pub3-BIB0011|cit12","first-page":"Abstract number","article-title":"A randomized trial evaluating long-term low-molecular weight heparin therapy for three months versus intravenous heparin followed by warfarin sodium","volume":"1 Suppl 1","author":"Hull","year":"2003","journal-title":"Journal of Thrombosis and Haemostasis"},{"key":"10.1002\/14651858.CD002001.pub3-BIB0013|cit13","first-page":"Abstract 1882","article-title":"Does rebound exist? A comparison of venous thromboembolitic event rates in the post-treatment period for patients randomized to long-term low-molecular-weight heparin vs. warfarin sodium","volume":"1 Suppl 1","author":"Pineo","year":"2003","journal-title":"Journal of Thrombosis and Haemostasis"},{"issue":"8","key":"10.1002\/14651858.CD002001.pub3-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.amjmed.2008.12.023","article-title":"Home therapy of venous thrombosis with long-term LMWH versus usual care: patient satisfaction and post-thrombotic syndrome","volume":"122","author":"Hull","year":"2009","journal-title":"American Journal of Medicine"},{"issue":"June","key":"10.1002\/14651858.CD002001.pub3-BIB0015|cit15","first-page":"Abstract No PS-","article-title":"A randomised trial comparing the effects of long-term low-molecular weight heparin (LMWH) with LMWH plus warfarin on the quality of life and safety in the home treatment of proximal deep vein thrombosis (DVT): the home-LITE study","volume":"77 Suppl","author":"Hull","year":"1997","journal-title":"Thrombosis and Haemostasis"},{"issue":"11","key":"10.1002\/14651858.CD002001.pub3-BIB0017|cit16","first-page":"Abstract 1951","article-title":"Does rebound exist? A comparison of venous thromboembolic (VTE) event rates in the post-treatment period for patients randomised to long-term low-molecular-weight heparin (LMWH) versus warfarin sodium","volume":"100","author":"Hull","year":"2002","journal-title":"Blood"},{"issue":"1","key":"10.1002\/14651858.CD002001.pub3-BIB0016|cit17","first-page":"Abstract OC1647","article-title":"Home-LITE: safety and efficacy results for a study investigating the long-term out-of hospital treatment of patients with proximal venous thrombosis using subcutaneous low-molecular-weight heparin versus warfarin","volume":"86","author":"Hull","year":"2001","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1002\/14651858.CD002001.pub3-BIB0018|cit18","first-page":"Abstract 1882","article-title":"Does rebound exist? A comparison of venous thromboembolitic event rates in the post-treatment period for patients randomized to long-term low-molecular-weight heparin vs. warfarin sodium","volume":"1 Suppl 1","author":"Pineo","year":"2003","journal-title":"Journal of Thrombosis and Haemostasis"},{"key":"10.1002\/14651858.CD002001.pub3-BIB0019|cit19","first-page":"Abstract OC 967","article-title":"Objective assessment of acute and long term treatment with unfractionated heparin and low molecular weight heparin in acute deep vein thrombosis","volume":"86 Suppl","author":"Kakkar","year":"2001","journal-title":"Thrombosis and Haemostasis"},{"issue":"4","key":"10.1002\/14651858.CD002001.pub3-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1055\/s-0037-1613574","article-title":"Low-molecular-weight heparin in the acute and longterm treatment of deep vein thrombosis","volume":"89","author":"Kakkar","year":"2003","journal-title":"Thrombosis and Haemostasis"},{"issue":"4","key":"10.1002\/14651858.CD002001.pub3-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1191\/1358863x05vm634oa","article-title":"Extended enoxaparin monotherapy for acute symptomatic pulmonary embolism","volume":"10","author":"Kucher","year":"2005","journal-title":"Vascular Medicine"},{"issue":"1","key":"10.1002\/14651858.CD002001.pub3-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1055\/s-0037-1614412","article-title":"Low molecular weight heparin versus acenocoumarol in the secondary prophylaxis of deep vein thrombosis","volume":"81","author":"Lopaciuk","year":"1999","journal-title":"Thrombosis and Haemostasis"},{"issue":"1","key":"10.1002\/14651858.CD002001.pub3-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1067\/mva.2001.109336","article-title":"Low molecular weight heparin versus oral anticoagulants in the long-term treatment of deep venous thrombosis","volume":"33","author":"Lopez-Beret","year":"2001","journal-title":"Journal of Vascular Surgery"},{"issue":"2","key":"10.1002\/14651858.CD002001.pub3-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0049-3848(03)00059-8","article-title":"An open-label randomized controlled trial of low molecular weight heparin compared to heparin and coumadin for the treatment of venous thromboembolic events in children: the REVIVE trial","volume":"109","author":"Massicotte","year":"2003","journal-title":"Thrombosis Research"},{"issue":"8","key":"10.1002\/14651858.CD002001.pub3-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1097\/MBC.0b013e3283401406","article-title":"Comparison of tinzaparin and acenocoumarol for the secondary prevention of venous thromboembolism: a multicentre, randomized study","volume":"21","author":"P\u00e9rez-de-Llano","year":"2010","journal-title":"Blood Coagulation & Fibrinolysis"},{"issue":"2","key":"10.1002\/14651858.CD002001.pub3-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1055\/s-0038-1648837","article-title":"Low molecular weight heparin versus warfarin in the prevention of recurrences after deep vein thrombosis","volume":"72","author":"Pini","year":"1994","journal-title":"Thrombosis and Haemostasis"},{"issue":"3","key":"10.1002\/14651858.CD002001.pub3-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.ejvs.2008.11.030","article-title":"A randomised open-label trial comparing long-term sub-cutaneous low-molecular-weight heparin compared with oral-anticoagulant therapy in the treatment of deep venous thrombosis","volume":"37","author":"Romera","year":"2009","journal-title":"European Journal of Vascular and Endovascular Surgery"},{"key":"10.1002\/14651858.CD002001.pub3-BIB0028|cit28","unstructured":"Romera-Villegas A Cairols MA Marti-Mestre X Riera-Batalla S Martinez-Rico C Effect of the anticoagulant therapy in the thrombus regression: a prospective duplex ultrasound study Phlebology\/Eleventh Meeting of the European Venous Forum:Antwerp, Belgium, 24-26 June 2010 2010 302 3"},{"issue":"4","key":"10.1002\/14651858.CD002001.pub3-BIB0029|cit29","first-page":"559","article-title":"Low molecular weight heparin (enoxaparin) versus oral anticoagulant therapy (acenocoumarol) in the long-term treatment of deep venous thrombosis in the elderly: a randomized trial","volume":"84","author":"Veiga","year":"2000","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1002\/14651858.CD002001.pub3-BIB0030|cit30","first-page":"Abstract: PP-WE","article-title":"A randomized, prospective, open-label study on distal vein thrombosis (low-molecular-weight heparin vs. warfarin for 6 weeks): the Todi study","volume":"7 Suppl 2","author":"Ghirarduzzi","year":"2009","journal-title":"Journal of Thrombosis and Haemostasis"},{"issue":"11","key":"10.1002\/14651858.CD002001.pub3-BIB0031|cit31","first-page":"Abstract 1873","article-title":"A randomized trial evaluating long-term low-molecular weight heparin therapy out-of-hospital versus warfarin sodium comparing the post-phlebitic outcomes at three months","volume":"98","author":"Hull","year":"2001","journal-title":"Blood"},{"issue":"11","key":"10.1002\/14651858.CD002001.pub3-BIB0032|cit32","first-page":"Abstract 1124","article-title":"Long-term out-of hospital treatment with low-molecular-weight heparin versus warfarin sodium: a randomised trial comparing the quality of life associated with these antithrombotic therapies","volume":"98","author":"Hull","year":"2001","journal-title":"Blood"},{"issue":"9","key":"10.1002\/14651858.CD002001.pub3-BIB0033|cit33","first-page":"57","article-title":"Warfarin or enoxaparin: the choice for the patient with venous thrombosis in the first month of treatment [Russian]","volume":"81","author":"Vorobyeva","year":"2009","journal-title":"Therapeutic Archives"},{"issue":"7","key":"10.1002\/14651858.CD002001.pub3-BIB0034|cit34","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006650.pub4","article-title":"Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer","author":"Akl","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"23 Suppl 1","key":"10.1002\/14651858.CD002001.pub3-BIB0035|cit35","first-page":"I","article-title":"Risk factors for venous thromboembolism","volume":"107","author":"Anderson","year":"2003","journal-title":"Circulation"},{"issue":"7454","key":"10.1002\/14651858.CD002001.pub3-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1136\/bmj.328.7454.1490","article-title":"Grading quality of evidence and strength of recommendations","volume":"328","author":"Atkins","year":"2004","journal-title":"BMJ"},{"issue":"4","key":"10.1002\/14651858.CD002001.pub3-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1160\/TH11-08-0565","article-title":"The treatment of venous thromboembolism with low-molecular-weight heparins. A meta-analysis","volume":"107","author":"Bochenek","year":"2012","journal-title":"Thrombosis and Haemostasis"},{"issue":"5","key":"10.1002\/14651858.CD002001.pub3-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/S0741-5214(96)70007-1","article-title":"Progression of superficial venous thrombosis to deep vein thrombosis","volume":"24","author":"Chengelis","year":"1996","journal-title":"Journal of Vascular Surgery"},{"issue":"3","key":"10.1002\/14651858.CD002001.pub3-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/sim.4780060308","article-title":"Avoidance of large biases and large random errors in the assessment of moderate treatment effects: the need for systematic overviews","volume":"6","author":"Collins","year":"1987","journal-title":"Statistics in Medicine"},{"issue":"2","key":"10.1002\/14651858.CD002001.pub3-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1053\/j.seminhematol.2007.02.004","article-title":"Epidemiology and risk factors for venous thrombosis","volume":"44","author":"Cushman","year":"2007","journal-title":"Seminars in Hematology"},{"issue":"6","key":"10.1002\/14651858.CD002001.pub3-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1378\/chest.130.6.1808","article-title":"Is recurrent venous thromboembolism after therapy reduced by low-molecular-weight heparin compared with oral anticoagulants?","volume":"130","author":"Ferretti","year":"2006","journal-title":"Chest"},{"issue":"19","key":"10.1002\/14651858.CD002001.pub3-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1056\/NEJM199311043291901","article-title":"A comparison of real-time compression ultrasonography with impedance plethysmography for the diagnosis of deep-vein thrombosis in symptomatic outpatients","volume":"329","author":"Heijboer","year":"1993","journal-title":"The New England Journal of Medicine"},{"key":"10.1002\/14651858.CD002001.pub3-BIB0043|cit43","doi-asserted-by":"publisher","first-page":"464-74","DOI":"10.1038\/nrcardio.2015.83.","article-title":"Epidemiology of venous thromboembolism","volume":"12","author":"Heit","year":"2015","journal-title":"Nature Reviews Cardiology"},{"key":"10.1002\/14651858.CD002001.pub3-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/00063198-199807000-00007","article-title":"Low molecular weight heparin versus unfractionated heparin in the initial treatment of venous thromboembolism","volume":"4","author":"Hettiarachchi","year":"1998","journal-title":"Current Opinion in Pulmonary Medicine"},{"key":"10.1002\/14651858.CD002001.pub3-BIB0045|cit45","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 www.cochrane-handbook.org"},{"issue":"13","key":"10.1002\/14651858.CD002001.pub3-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1056\/NEJM198603273141305","article-title":"Serial impedance plethysmography for suspected deep venous thrombosis in outpatients. The Amsterdam General Practitioner Study","volume":"314","author":"Huisman","year":"1986","journal-title":"New England Journal of Medicine"},{"issue":"3","key":"10.1002\/14651858.CD002001.pub3-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1001\/archinte.1989.00390030017004","article-title":"Management of clinically suspected acute venous thrombosis in outpatients with serial impedance plethysmography in a community hospital setting","volume":"149","author":"Huisman","year":"1989","journal-title":"Archives of Internal Medicine"},{"issue":"16","key":"10.1002\/14651858.CD002001.pub3-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1056\/NEJM197910183011602","article-title":"Warfarin sodium versus low-dose heparin in the long-term treatment of venous thrombosis","volume":"301","author":"Hull","year":"1979","journal-title":"The New England Journal of Medicine"},{"issue":"4","key":"10.1002\/14651858.CD002001.pub3-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1056\/NEJM198201283060401","article-title":"Adjusted subcutaneous heparin versus warfarin sodium in the long-term treatment of venous thrombosis","volume":"306","author":"Hull","year":"1982","journal-title":"The New England Journal of Medicine"},{"issue":"27","key":"10.1002\/14651858.CD002001.pub3-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1056\/NEJM198212303072704","article-title":"Different intensities of oral anticoagulant therapy in the treatment of proximal-vein thrombosis","volume":"307","author":"Hull","year":"1982","journal-title":"The New England Journal of Medicine"},{"issue":"1","key":"10.1002\/14651858.CD002001.pub3-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"21","DOI":"10.7326\/0003-4819-102-1-21","article-title":"Diagnostic efficacy of impedance plethysmography for clinically suspected deep-vein thrombosis. A randomized trial","volume":"102","author":"Hull","year":"1985","journal-title":"Annals of Internal Medicine"},{"issue":"20","key":"10.1002\/14651858.CD002001.pub3-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1001\/archinte.1997.00440410049005","article-title":"The importance of initial heparin treatment on long-term clinical outcomes of antithrombotic therapy. The emerging theme of delayed recurrence","volume":"157","author":"Hull","year":"1997","journal-title":"Archives of Internal Medicine"},{"key":"10.1002\/14651858.CD002001.pub3-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s003900070014","article-title":"A randomized trial of the effect of low molecular weight heparin vs. warfarin on mortality in the long-term treatment of proximal vein thrombosis","volume":"37 Suppl 1","author":"Hull","year":"2000","journal-title":"Intensivmedizin und Notfallmedizin"},{"key":"10.1002\/14651858.CD002001.pub3-BIB0054|cit54","first-page":"148a","article-title":"A randomized trial evaluating long-term low-molecular-weight heparin therapy for three months versus intravenous heparin followed by warfarin sodium [abstract]","volume":"100","author":"Hull","year":"2002","journal-title":"Blood"},{"issue":"4","key":"10.1002\/14651858.CD002001.pub3-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"303","DOI":"10.2165\/00002512-199914040-00005","article-title":"Safety of treatment with oral anticoagulants in the elderly. A systematic review","volume":"14","author":"Hutten","year":"1999","journal-title":"Drugs and Aging"},{"issue":"9","key":"10.1002\/14651858.CD002001.pub3-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1046\/j.1538-7836.2003.00364.x","article-title":"Low-molecular-weight heparin for the long-term treatment of symptomatic venous thromboembolism: meta-analysis of the randomised comparisons with oral anticoagulants","volume":"1","author":"Iorio","year":"2003","journal-title":"Journal of Thrombosis and Haemostasis"},{"issue":"2","key":"10.1002\/14651858.CD002001.pub3-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.chest.2015.11.026","article-title":"Antithrombotic therapy for VTE disease: CHEST Guideline and Expert Panel Report","volume":"149","author":"Kearon","year":"2016","journal-title":"Chest"},{"issue":"6","key":"10.1002\/14651858.CD002001.pub3-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1093\/ajcp\/104.6.611","article-title":"Diagnosis of heparin-induced thrombocytopenia. Still a journey, not yet a destination","volume":"104","author":"Kelton","year":"1995","journal-title":"American Journal of Clinical Pathology"},{"issue":"11","key":"10.1002\/14651858.CD002001.pub3-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1056\/NEJM199603143341102","article-title":"Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home. The Tasman Study Group","volume":"334","author":"Koopman","year":"1996","journal-title":"The New England Journal of Medicine"},{"issue":"8454","key":"10.1002\/14651858.CD002001.pub3-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S0140-6736(85)90459-3","article-title":"Need for long-term anticoagulant treatment in symptomatic calf-vein thrombosis","volume":"2","author":"Lagerstedt","year":"1985","journal-title":"Lancet"},{"issue":"11","key":"10.1002\/14651858.CD002001.pub3-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1056\/NEJM199603143341101","article-title":"A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis","volume":"334","author":"Levine","year":"1996","journal-title":"The New England Journal of Medicine"},{"issue":"4","key":"10.1002\/14651858.CD002001.pub3-BIB0062|cit62","first-page":"719","article-title":"Statistical aspects of the analysis of data from retrospective studies of disease","volume":"22","author":"Mantel","year":"1959","journal-title":"Journal of the National Cancer Institute"},{"issue":"5","key":"10.1002\/14651858.CD002001.pub3-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1002\/bjs.1800780528","article-title":"Comparison of duplex ultrasonography and venography in the diagnosis of deep venous thrombosis","volume":"78","author":"Mitchell","year":"1991","journal-title":"British Journal of Surgery"},{"issue":"1","key":"10.1002\/14651858.CD002001.pub3-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1055\/s-0038-1642376","article-title":"Comparison of subcutaneous unfractionated heparin with a low molecular weight heparin (Fragmin) in patients with venous thromboembolism and contraindications to coumarin","volume":"71","author":"Monreal","year":"1994","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1002\/14651858.CD002001.pub3-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"h2039","DOI":"10.1136\/bmj.h2039","article-title":"Superficial thrombophlebitis (superficial venous thrombosis)","volume":"350","author":"Nasr","year":"2015","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD002001.pub3-BIB0066|cit66","unstructured":"National Clinical Guideline Centre Venous thromboembolism: reducing the risk of venous thromboembolism (deep vein thrombosis and pulmonary embolism) in patients admitted to hospital. Methods, evidence and guidance http:\/\/www.nice.org.uk\/guidance\/cg92\/evidence\/cg92-venous-thromboembolism-reducing-the-risk-full-guideline3 (accessed September 2015)"},{"key":"10.1002\/14651858.CD002001.pub3-BIB0067|cit67","unstructured":"National Clinical Guideline Centre Venous thromboembolic diseases: the management of venous thromboembolic diseases and the role of thrombophilia testing. Clinical Guideline. Methods, evidence and recommendations http:\/\/www.nice.org.uk\/guidance\/cg144\/evidence\/cg144-venous-thromboembolic-diseases-full-guideline3 (accessed September 2015)"},{"issue":"6","key":"10.1002\/14651858.CD002001.pub3-BIB0068|cit68","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010956.pub2","article-title":"Oral direct thrombin inhibitors or oral factor Xa inhibitors for the treatment of deep vein thrombosis","author":"Robertson","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"12","key":"10.1002\/14651858.CD002001.pub3-BIB0069|cit69","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010957.pub2","article-title":"Oral direct thrombin inhibitors or oral factor Xa inhibitors for the treatment of pulmonary embolism","author":"Robertson","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"5","key":"10.1002\/14651858.CD002001.pub3-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1055\/s-0037-1614550","article-title":"Safety of low-molecular-weight heparin in pregnancy: a systematic review","volume":"81","author":"Sanson","year":"1999","journal-title":"Thrombosis and Haemostasis"},{"issue":"20","key":"10.1002\/14651858.CD002001.pub3-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1056\/NEJM199505183322003","article-title":"Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin","volume":"332","author":"Warkentin","year":"1995","journal-title":"The New England Journal of Medicine"},{"key":"10.1002\/14651858.CD002001.pub3-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"I","DOI":"10.1161\/01.CIR.0000078468.11849.66","article-title":"The epidemiology of venous thromboembolism","volume":"107","author":"White","year":"2003","journal-title":"Circulation"},{"issue":"10","key":"10.1002\/14651858.CD002001.pub3-BIB0073|cit73","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002001.pub2","article-title":"Vitamin K antagonists or low-molecular-weight heparin for the long term treatment of symptomatic venous thromboembolism","author":"Andras","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD002001.pub3-BIB0074|cit74","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002001","article-title":"Vitamin K antagonists or low-molecular-weight heparin for the long term treatment of symptomatic venous thromboembolism","author":"Heijden","year":"2001","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD002001.pub3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,24]],"date-time":"2021-08-24T04:48:46Z","timestamp":1629780526000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD002001.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Vascular Group","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2017,7,24]]},"references-count":74,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2017,7]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd002001.pub3","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,24]]}}}